Skip to main content
Top
Published in: Journal of Cancer Survivorship 6/2022

30-10-2021 | Breast Cancer | Correction

Correction to: Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study

Authors: An De Groef, Nele Devoogdt, Ceren Gursen, Niamh Moloney, Victoria Warpy, Jolien Daelemans, Lore Dams, Vincent Haenen, Elien Van der Gucht, An‑Kathleen Heroes, Tessa De Vrieze, Elizabeth Dylke

Published in: Journal of Cancer Survivorship | Issue 6/2022

Login to get access

Excerpt

Correction to: Journal of Cancer Survivorship
Metadata
Title
Correction to: Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study
Authors
An De Groef
Nele Devoogdt
Ceren Gursen
Niamh Moloney
Victoria Warpy
Jolien Daelemans
Lore Dams
Vincent Haenen
Elien Van der Gucht
An‑Kathleen Heroes
Tessa De Vrieze
Elizabeth Dylke
Publication date
30-10-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01125-4

Other articles of this Issue 6/2022

Journal of Cancer Survivorship 6/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine